• 109 Citations
  • 6 h-Index
20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alyson Haslam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Mindfulness Medicine & Life Sciences
Adenoma Medicine & Life Sciences
Meditation Medicine & Life Sciences
Valsartan Medicine & Life Sciences
Hand Strength Medicine & Life Sciences
Diet Medicine & Life Sciences
Anemia Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

5 Citations (Scopus)

A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals

Herrera-Perez, D., Haslam, A., Crain, T., Gill, J., Livingston, C., Kaestner, V., Hayes, M., Morgan, D., Cifu, A. S. & Prasad, V., 1 Jun 2019, In : eLife. 8, e45183.

Research output: Contribution to journalArticle

Open Access
New England
American Medical Association
Medicine
Cardiovascular Diseases
Randomized Controlled Trials
20 Citations (Scopus)

A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology

Haslam, A., Hey, S. P., Gill, J. & Prasad, V., 1 Jan 2019, In : European Journal of Cancer. 106, p. 196-211 16 p.

Research output: Contribution to journalReview article

Meta-Analysis
Validation Studies
Biomarkers
Survival
Randomized Controlled Trials
3 Citations (Scopus)

Confirmatory Trials for Drugs Approved on a Single Trial

Haslam, A. & Prasad, V., 1 Jun 2019, In : Circulation. Cardiovascular quality and outcomes. 12, 6, p. e005494

Research output: Contribution to journalArticle

Valsartan
Drug Approval
Fish Oils
Pharmaceutical Preparations

Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib

de Almeida Carvalho, L. M., de Oliveira Sapori Avelar, S., Haslam, A., Gill, J. & Prasad, V., 1 Nov 2019, In : JAMA network open. 2, 11, p. e1916091

Research output: Contribution to journalArticle

Open Access
Off-Label Use
Fibroblast Growth Factor Receptors
Neoplasms
Gene Targeting
Pharmaceutical Preparations
22 Citations (Scopus)
Open Access
Immunotherapy
Pharmaceutical Preparations
Neoplasms
United States Food and Drug Administration
Melanoma